Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,727 | -3,265 | -2,358 | -756 | -383 |
| Accounts payable and accrued liabilities | -41 | 47 | -28 | 15 | 17 |
| Other Working Capital | 45 | -118 | -99 | 58 | -31 |
| Other Operating Activity | 697 | 1,205 | 1,093 | -86 | -17 |
| Operating Cash Flow | $-1,026 | $-2,131 | $-1,392 | $-769 | $-414 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,707 | 4,602 | N/A | N/A | N/A |
| Other Financing Activity | -11 | 0 | -130 | -56 | 0 |
| Financing Cash Flow | $3,696 | $4,602 | $-130 | $-56 | $N/A |
| Beginning Cash Position | 5,069 | 2,599 | 2,599 | 2,599 | 2,599 |
| End Cash Position | 7,739 | 5,069 | 1,076 | 1,774 | 2,185 |
| Net Cash Flow | $2,670 | $2,470 | $-1,523 | $-825 | $-414 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,026 | -2,131 | -1,392 | -769 | -414 |
| Free Cash Flow | -1,026 | -2,131 | -1,392 | -769 | -414 |